Morphometric prognostic index in breast cancer

Analytical and Quantitative Cytology and Histology

Volumn 21, Issue 3, 1999, Pages 250-254

  Carbone, Arnaldo ^a   Serra, Fabio Giosuè ^b   Rinelli, Alessandro ^b   Terribile, Daniela ^b   Valentini, Miriam ^b   Bellantone, Rocco ^b   Rossi, Simona ^b   Ausili Cèfaro, Giampiero ^b   Nardone, Luigia ^b   Piantelli, Mauro ^b   Capelli, Arnaldo ^b   Ranelletti, Franco Oreste ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

Breast neoplasms; Morphometry; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CELL CYCLE S PHASE; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CYTOSOL; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE CYTOMETRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MITOTIC INDEX; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; S PHASE;

EID: 0032975433     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Baak JPA, van DOP H, Kurver PHJ, Hermans J: The value of morphometry to classic prognosticators in breast cancer. Cancer 1985;56:374-382
2. Bonadonna G, Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 1981;304:10-15
3. Carbone A, Vecchio FM: Presence of cytoplasmic progesterone receptors in hepatic adenomas: Report of two cases. Am J Clin Pathol 1986;85:325-329
4. Clayton F: Pathological correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Cancer 1991;68:1309-1317
5. van Diest PJ, Baak JPA: The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 1991;22:326-330
6. van Diest PJ, Jannink I, Matze-Cok E, Baak JPA: Comparative prognostic value of lymph node metastases and primary tumor quantitative variables in breast cancer. Electr J Pathol Histol 1995;1.2:952-1002
7. McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 1992;326:1756-1761
8. McGuire WL, Tandon AK, Allred DG, Chamness GC, Clark GM: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 1990;82: 1006-1015
9. Piffanelli A, Fumero S, Pelizzola D, Berruto GP, Ricci L, Giovannini G: Protocollo del metodo con Charcoal-destrano (D.C.C.) per il dosaggio dei recettori dell' estradiolo e del progesterone nel tessuto neoplastico (Uniform D.C.C. method for estradiol and progesterone receptor assay on tumor tissue). LAB J Res Lab Med 1982;IX:13-21
10. Thornthwaite JT, Thomas RA: High-resolution DNA measurements using the Nuclear Isolation Medium - DAPI with the RATCOM flow cytometer. Meth Cell Biol 1990;33: 111-119